Search

everythinglearnresearchcommunity

for

Search:↓

PCA hydrogel promotes hair growth by enhancing blood vessel formation and hair follicle stem cell activity.

UVA-1 phototherapy might help treat alopecia areata.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Astrotactin-2 is cleaved in a specific way that helps understand its maturation.

The document's content couldn't be processed to provide a conclusion.

The document's content couldn't be processed to provide a conclusion.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

CuATSM speeds up wound healing and reduces scarring.

The document could not be understood or processed.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

I'm sorry, but I cannot process the document as it is not in English. If you provide an English summary or conclusion, I can help summarize that for you.

Mutations in iRhom2 affect hair and skin in mice and are linked to esophageal cancer, with ADAM17 playing a crucial role.

The document could not be processed or understood.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

Baricitinib is effective and safe for long-term treatment of severe alopecia areata.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

SSAT is a key enzyme affecting cell growth and metabolism, with potential but risky use in disease treatment.

Genetic testing is crucial for diagnosing congenital atrichia, a rare condition causing irreversible hair loss.

Baricitinib successfully treated severe hair loss.

Irish dermatologists urgently need guidelines for using JAK inhibitors in treating alopecia areata.

A new mutation in the ST14 gene causes a rare skin and hair disorder in a specific family.

The name Janus is fitting for JAK inhibitors as they revolutionize dermatology treatments.

A Japanese patient with a rare genetic disorder had a less severe case than others, suggesting other factors may affect symptoms.

The Intruder is a tool used for safely preparing the area where a donor's tissue is taken.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.